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Abstract
Background: The availability of data generated from different sources is increasing with the possibility to link these
data sources with each other. However, linked administrative data can be complex to use and may require
advanced expertise and skills in statistical analysis. The main objectives of this study were to describe the current
use of data linkage at the individual level and artificial intelligence (AI) in routine public health activities, to identify
the related estimated health indicators (i.e., outcome and intervention indicators) and health determinants of non-
communicable diseases and the obstacles to linking different data sources.
Method: We performed a survey across European countries to explore the current practices applied by national
institutes of public health, health information and statistics for innovative use of data sources (i.e., the use of data
linkage and/or AI).
Results: The use of data linkage and AI at national institutes of public health, health information and statistics in
Europe varies. The majority of European countries use data linkage in routine by applying a deterministic method
or a combination of two types of linkages (i.e., deterministic & probabilistic) for public health surveillance and
research purposes. The use of AI to estimate health indicators is not frequent at national institutes of public health,
health information and statistics. Using linked data, 46 health outcome indicators, 34 health determinants and 23
health intervention indicators were estimated in routine. The complex data regulation laws, lack of human
resources, skills and problems with data governance, were reported by European countries as obstacles to routine
data linkage for public health surveillance and research.
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Conclusions: Our results highlight that the majority of European countries have integrated data linkage in their
routine public health activities but only a few use AI. A sustainable national health information system and a robust
data governance framework allowing to link different data sources are essential to support evidence-informed
health policy development. Building analytical capacity and raising awareness of the added value of data linkage in
national institutes is necessary for improving the use of linked data in order to improve the quality of public health
surveillance and monitoring activities.
Keywords: Innovation, Linked data, Artificial intelligence, Machine learning technique, Health status monitoring,
Public health surveillance, Health information, Health indicators
Background
The availability of administrative data generated from
different sources is increasing. The possibility to link
these data sources with other databases offers unique
opportunities to answer those research questions, which
require a large sample size or detailed data on hard-to-
reach populations. This methodology link available in-
formation from different sources and can generate evi-
dence at population level with a high level of external
validity and relevance for policy making [1]. Over an ex-
tensive period, data linkage ensures a high statistical
power, thereby reducing methodological issues relating
to attrition, recall bias and lost-to-follow up [2]. This
technique also allows performing more detailed stratified
analyses of subgroups according to age, or specific geo-
graphical regions, and providing rapid access to data col-
lected in a standardized format [3–5].
The value of any surveillance system ultimately de-
pends on timely and reliable information [6]. There are
several data sources, which are used for public health
surveillance, for example, health interviews and examin-
ation surveys, diseases-specific registries, epidemiological
cohort studies, hospital discharge data, health insurance
claims, mortality database, etc. Traditional data sources
(e.g., health interview and examination surveys, disease-
specific registries, etc.) and administrative data sources
(e.g., hospital discharge, health insurance claims, causes
of mortality data, etc.) complement each other and can
increase the completeness and comprehensiveness of
health information by taking into account various di-
mensions of health and risk factors influencing health
status directly and indirectly.
Linking various data sources improves the complete-
ness and comprehensiveness of information to guide
health policy process, effective patient care and health
services management [7]. Data linkage is an important
technique that connects detailed information about indi-
viduals or entities from different data sources to enrich
or create new data source. This methodology potentiate
the capacity to study disease burden and progression,
risk factors, care pathways and long-term outcomes for
public health research and health surveillance [1]. Many
countries have already invested in data linkage to im-
prove their health information system [8], but there are
wide differences in capacity across European countries
to perform data linkage in routine. However, linked ad-
ministrative data can be complex to use and may require
advanced expertise and skills in statistical analysis [9].
Generating efficiently comparable and timely health in-
formation across European Union (EU), European
Economic Area (EEA) and other European countries re-
quires skills and expertise in performing data linkage
and applying AI to estimate health indicators. Artificial
intelligence (AI), also known as machine intelligence, is
a branch of computer science that aims to imbue soft-
ware with the ability to analyze its environment using ei-
ther predetermined rules and search algorithms, or
pattern recognizing machine learning models, and then
make decisions based on those analyses [10]. Machine
learning is an application of AI and is often applied for
the diagnosis of certain medical conditions as well as
outcome prediction and prognosis evaluation with high
precision [11].
We explored the differential use of data linkage in rou-
tine health monitoring based on the latest developments
in new methods and analysis across European countries.
This study was carried out under the InfAct (Informa-
tion for Action) project [12] which is a joint action of
Member States aiming to develop a more sustainable EU
health information system through improving the avail-
ability of comparable, robust and policy-relevant health
status data and health system performance information.
InfAct gathers 40 national health authorities from 28
Member States (MSs). This study is part of a work pack-
age (WP9) focused on innovation in health information
system (i.e., using data linkages and/or AI) to improve
public health surveillance and health system perform-
ance for health policy development. The main objectives
of this study were 1. to describe the current use of data
linkage at the individual level and AI techniques applied
in routine public health activities, 2. to identify the rele-
vant health indicators (i.e., outcome and intervention in-
dicators) estimated and health determinants of non-
communicable diseases and 3. to identify that what are
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the obstacles to linking different data sources in routine
public health surveillance and research.
Methodology
We performed the following steps to achieve the objec-
tives of this study:
Literature search
We reviewed the existing literature published on the use
of data linkage and AI (i.e., one technique of AI is ma-
chine learning) for health status monitoring using
PubMed on Dec. 1, 2018. We included in our search
peer-reviewed articles, systematic reviews and published
reports in English language. The search strategies are re-
ported in additional file 1. Based on this review, we iden-
tified different data sources used for data linkage, the
use of artificial intelligence [AI]), health outcome and
intervention indicators and determinants of health (Add-
itional file 2). This was not an exhaustive search and it
was performed only to identify any pre-existing ques-
tionnaire or relevant information that could be used for
the development of our survey on the current practices
in innovative use of data sources across European
countries.
Definition of innovative use of data sources
We developed the definition of “innovative use of data
sources” in the context of public health and health infor-
mation system activities and defined as:
 The linkage of different data sources (health surveys
and/or disease-specific or population-based registries
and/or national cohort and/or clinical research data-
sets and/or administrative data and/or electronic
health records and/or X-data sources i.e., informa-
tion on determinants of health and can include data
on various exposures [Additional file 2]) with each
other using linkage technology and/or
 The use of AI either applied to linked data or to an
individual data set,
allowing a better understanding of what determines
population health or to promote the efficiency of the
health system and guide decision making at different
geographical levels, or at another categorization param-
eter level.
Development of the web-based survey
We developed a questionnaire and requested informa-
tion from European countries on the data sources used
for linkage, general characteristics of the data linkage,
use of AI to estimate health indicators, related health
outcomes and intervention indicators estimated and
health determinants of non-communicable diseases. We
reported these results according to three levels of using
data linkage or AI in routine public health activities
across European countries: 1. Advanced (i.e., those who
use data linkage or AI in routine to estimate health indi-
cators), 2. In Progress (i.e., those for whom the deploy-
ment of these innovative techniques [i.e., data linkage or
AI] is still underway and expect to integrate these tech-
niques in the next 5 years), and 3. Not yet (i.e., those for
which the use of these techniques is not foreseen yet).
Survey participants were also asked to report at least
three health indicators, which are related to priority
medical conditions in their country. We adopted the
Euro-REACH Framework (i.e., it is a project based on an
international collaboration to improve access to health
care data through cross-country comparisons) [13] to
classify the identified health outcome indicators, deter-
minants of health and intervention indicators under the
following categories: health outcome indicators (1.
Health characteristics, 2. Mortality, 3. Human function
and quality of life and 4. Life expectancy and well-
being), determinants of health (1. Physical environment,
2. Socioeconomic and environment, 3. Health behavior
and life style and 4. Biological /metabolic parameters)
and intervention indicators (1. Prevention, 2. Promotion
and 3. Others). We also asked specific information on
the objective of estimation of health indicators (i.e., for
public health monitoring, scientific research [clinical,
epidemiology, public health], both), status of their use
(i.e., was used, currently in use or could be produced in
future) and level of estimation (i.e., national, sub-
national, metropolitan, at all levels). If the same health
indicator was reported more than once either as being
estimated currently or to be estimated in future by dif-
ferent countries, we counted those health indicators
once. The web-based questionnaire was developed using
the Lime Survey tool by the Data lab of Santé Publique
France. The questionnaire included both closed and
open-ended questions (i.e., 20 questions). This question-
naire was reviewed by a group of experts on health in-
formation systems in their country and was revised
according to their feedback before the launch of the sur-
vey. The web-based version of the questionnaire was
pretested by the co-authors (SME, RH and RG) from the
national public health institutes of Austria, France and
Lithuania respectively, to check the clarity of the ques-
tions and contents.
The survey participants were the partners of the
InfAct project and/or national representatives, experts,
health information advisors in their countries, employed
by their government, national institutes of public health,
health information and statistics institutes or research
departments of the universities.
The invitation email with an electronic link to the
questionnaire was sent on April 1, 2019, to the identified
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representatives in 31 European countries [28 EU-MSs +
2 EEA (Iceland and Norway) + Others (Serbia)] and they
were asked to complete the survey in four weeks (i.e.,
April 30, 2019). For the United Kingdom, data were pro-
vided separately by three countries England, Scotland
and Wales but counted as one member state. The first
reminder was sent via-email one month after the survey
launch, on May 3, 2019, and the second reminder an-
other two weeks later, on May 23, 2019. The abbrevia-
tions of the member countries and the names of the
survey respondents are reported in the additional file 3.
Study outcomes
The main outcomes of this study were the current data
linkage and AI practices and related health indicators esti-
mated in routine public health activities across European
countries. A descriptive analysis of the web-based ques-
tionnaire results was performed using Microsoft Excel.
Results
Literature search
We reviewed 137 citations from PubMed and four re-
ports from the following organizations: OECD
(Organization for Economic Co-operation and Develop-
ment) [14], Euro-REACH [15], HBM4EU (Human Bio-
monitoring for Europe) [16], EUROCISS (European
Cardiovascular Indicators Surveillance Set) [17], to de-
velop this questionnaire (Fig. 1).
Survey results
The survey results include the countries response, use of
data linkage in routine public health activities, use of AI
in routine public health activities, health indicators esti-
mated using linked data and main obstacles to linking
different data sources. All survey respondents have vali-
dated these results.
i. Countries response
Twenty-nine countries (i.e., EU MSs 27 + EEA 1
[Norway] + Others 1 [Serbia]) participated in the survey
with a response rate of 94% (29/31). Hungary, Iceland
and Northern Ireland did not participate.
ii. Use of data linkage in routine public health
activities
Our survey results highlight that 24 European countries
perform data linkage in their routine public health activ-
ities. These countries link administrative data such as
EHRs (Electronic Health Records), mortality data, and dis-
ease specific registries whereas six of them (Cyprus, Italy,
Poland, Portugal, Spain and Slovakia) are also developing
this technique further to link with other types of data
sources (i.e., demographic data, domestic/leisure accidents
data, congenital anomalies registry). Ireland and Latvia
have ongoing initiatives of data linkage (Table 1).
Three countries (Greece, Luxembourg and Romania)
have not yet planned to integrate data linkage in their
routine public health activities. The following reasons
were mentioned by some countries for not having insti-
tutionalized data linkage: lack of a public health institu-
tion, which should collect and govern the health related
data, data linkage is not part of the health agenda, lack
of commitment from the ministry of health, lack of re-
sources to establish a national health information sys-
tem, the institutional complexity of the Ministry of
Health and strict laws and regulations, which hinder
data linkage with different data sources.
Objectives of data linkage
Data linkage can be performed in routine for different
objectives such as for health status monitoring, health
system performance, health policy development or for
scientific research (i.e., public health, epidemiology or
clinical) purposes. Our results showed that data linkage
was performed for health status monitoring in 20 coun-
tries (BE, CY, CZ, DE, DK, EE, ES, FI, FR, HR, IT, LT,
MT, NL, PT, SI, SK, SRB, SW, UK (SC, WL), for health
policy development in 13 (AT, BE, BG, DK, EE, FR, MT,
NL, NO, PL, SK, SW, UK (SC, WL) and for scientific re-
search (public health, epidemiological and clinical) pur-
poses in 13 (BE, CZ, DE, DK, EE, ES, FI, FR, NL, PT, SI,
SW, UK (ENG, SC, WL). Finland, Spain, Sweden and
Scotland also perform data linkages to identify popula-
tion risk factors. In Sweden, data linkage is also used to
monitor compliance with national treatment guidelines
to improve health care quality.
Data sources used for linkage
Our results showed that 24 European countries, who
perform data linkage in routine, use most frequently the
five following types of data sources: health-related ad-
ministrative data sources, non-health related administra-
tive data sources, disease-specific registries, national
health surveys, population-based epidemiological cohort
and clinical trials (Additional file 4). These data sources
are linked with each other in different combinations and
some examples of the various combinations used across
member countries, are reported in additional file 5.
These countries perform data linkage based on the fol-
lowing information: social security number, patient
unique identification number, person unique pseud-
onymous identifier, encrypted personal identification
number, citizen or national identification number. In
some countries, for instance in Ireland, the lack of
unique patient identifier number, limits the potential to
link with different data sources.
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General characteristics of linked dataset
Our results showed that among 24 European countries
who perform data linkage in routine, 17 do linkage at
national level (Table 2). France, Portugal and Scotland
do data linkage both at national and sub-national levels.
Denmark, Germany, Norway and Sweden do data link-
age at all levels. 23 countries either perform the deter-
ministic type of linkage (12 countries) or a combination
of deterministic and probabilistic linkage (11 countries).
In 16 out of 24 countries, linked data is available and is
Fig. 1 Flow diagram of studies using linked data and artificial intelligence for health status monitoring to develop a survey on identifying various
data linkage practices across European countries in 2019. *To be more specific for AI techniques, we looked for studies using machine learning
techniques (i.e., one type of AI technique) more often used for health status monitoring
Table 1 Use of data linkage for routine public health activities in European countries in 2019









AT, BE, BG, CY, CZ, DE, DK, EE, ES, FI, FR, HR, IT, LT, MT, NL, NO, PL, PT, SI, SK, SRB, SW, UK
(ENG, SC, WL)




* 6 countries (CY, ES, IT, PL, PT & SK) use data linkage in routine (i.e., advanced) but also developing further this technology to link different other data sources
(i.e., in progress)
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used in routine. In 12 out of 24 countries, the register
owner (i.e., who governs the data register) provides the
approval to access linked data. In 15 out of 24 countries,
the accessibility to linked data is in routine or perman-
ent whereas, in 13 countries, the accessibility could be
ad-hoc or at intermittent basis depending on the project.
In 15 out of 24 countries, linked data do not operate in
real-time (i.e., integrate the updated information with
minimum delay in time). In 19 out of 24 countries,
linked data are flexible to integrate new variables.
There are ongoing projects to integrate data linkage
(i.e., in next five years) as part of this technology in their
Table 2 General characteristics of linked datasets in European countries in 2019
S/
No






1 Level of data linkage use/implementation
National level 17 AT, BE, BG, CY, CZ, EE, ES, FI, HR, LT, MT, NL,
NO, SI, SK, SRB, UK (ENG, WL)
IE, LV
Sub-national level 1 IT
Both (National and Sub-national) levels 3 FR, PT, UK-SC
Metropolitan level 4 MT, PL, SI, UK-WL
All of above 4 DE, DK, NO, SW
2 Type of linkage
Deterministic 12 AT, CY, HR, FI, LT, MT, NL, NO, SI, SK, SRB, SW IE, LV
Probabilistic 1 UK-SC
Combination of both (i.e., deterministic and probabilistic) 11 BE, CZ, DE, DK, EE, ES, FR, IT, PL, PT, UK (ENG,
WL)
None of the above 1 BG
3 Current status of linked data usage
Available and is used in routine 16 AT, BE, CY, CZ, DK, EE, FI, FR, LT, MT, NL, NO,
PL, SI, SW, UK (ENG, SC, WL)
In progress of development 4 BG, ES, HR, PT IE, LV
Partial in use & partial in progress of development 2 DE, SK
Available but not in use 2 IT, SRB
4 Type of approval to access
By law 5 AT, CZ, MT, NO, SW
By ethical committee 7 BE, ES, FR, IT, NO, PT, UK (ENG, SC, WL)
By register owner 13 BG, CY, ES, HR, FI, FR, IT, NO, PL, PT, SI, SK, SRB
Others (i.e., depend on linkage/data protection inspector/under conditions/not
applicable (data linkage in safe environment)/by statistical authority
7 CZ, DE, DK, EE, ES, LT, NL LV
5 Type of accessibility
In routine/permanent 15 BE, BG, CZ, DK, EE, FI, FR, NL, NO, PL, PT, SI, SK,
SW, UK (ENG, SC, WL)
Ad-hoc/Intermittent 13 BE, CY, DE, EE, ES, HR, IT, FR, MT, NO, PT, SK,
SRB
Under conditions (i.e., restricted to certain projects for a limited period) 6 AT, EE, ES, FR, LT, NO LV
6 Operate in real-time
Yes 10 DK, EE, FI, FR, LT, NO, SI, SK, SW, UK-SC
No 15 AT, BE, BG, CY, CZ, DE, ES, HR, IT, MT, NL, PL,
PT, SRB, UK (ENG, WL)
IE, LV
7 Flexible to integrate new variables
Yes 19 AT, BG, CY, CZ, DE, DK, ES, FI, FR, HR, MT, NL,
NO, PL, PT, SI, SK, SW, UK (ENG, SC, WL)
No 5 BE, EE, IT, LT, SRB IE, LV
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routine public health activities in following European
countries: Austria, Cyprus, Czech Republic, Ireland,
Italy, Latvia, Norway, Poland, Portugal, and Spain.
iii. Use of artificial intelligence (AI) in routine
public health activities
The use of AI is not frequent across European coun-
tries (Table 3). Only five countries have reported apply-
ing the following techniques in routine public health
activities: machine learning (Denmark, Finland, Sweden,
and UK-Wales), natural language processing (Finland,
Sweden, and UK-Wales), Markov decision process
(Finland), support vector machine (Finland, UK-Wales),
data mining (Finland) and TSP [Travelling Salesman
Problem] modelling (Norway). Denmark can apply these
techniques not only at national level but also at metro-
politan level.
There are ongoing projects to integrate the use of AI
in routine public health activities in the next five years
in following countries: Croatia, Czech Republic, France,
Germany, Norway, Portugal, and Spain. The objectives
of these initiatives are for epidemiological research and
surveillance of non-communicable and communicable
disease estimating the prevalence and prediction of inci-
dences of certain health conditions at various geograph-
ical levels.
Two countries mentioned that due to lack of human
resources (Lithuania) and capacities/skills (Republic of
Serbia) within their public health institutes, AI tech-
niques are not applied in routine public health activities.
Some European countries also mentioned the use of
classical statistical techniques without the use of AI
(Table 3).
iv. Health indicators estimated using linked data
Using linked data, the majority of European countries
estimate the following health indicators:
Health outcome indicators
Participants were asked to select at least three health
conditions and to report the related health outcome in-
dicators, which are most important for public health in
their country. Using linked data, 46 health outcome indi-
cators related to the following seven health conditions
were reported from 22 countries: cardiovascular (14),
neurodegenerative disease (6), maternal and perinatal
health (6), diabetes (6), suicide/trauma/injury (7), cancer
(6) and hepatic failure (1) (Additional file 6). The main
objectives to estimate these indicators were for public
health monitoring and research purposes. The level of
estimation was mainly at national and sub-national
levels. These 46 health outcome indicators were classi-
fied according to the following categories: 1. health char-
acteristics, 2. mortality, 3. human function and quality of
life and 4. life expectancy and well-being. For example
for the first category, Czech Republic, France, Lithuania,
Table 3 Use of artificial intelligence in routine public health activities in European countries in 2019









DK, FI, NO, SW, UK-WL AT, CZ, DE, ES, FR,
HR, PL, PT, SK
BE, BG, CY, EE, GR, IE, IT, LT, LU, LV, MT, NL,
RO, SL, SRB, UK (ENG, SC)
Level of application of AI















BE, BG, CZ, DE, EE, ES, DK, FR, FI, IT, MT, NL, NO, PL, PT, SI, SK,
SW, UK (ENG, SC, WL)
AT, CZ, ES, HR, SK CY, GR, IE, LT, LU, LV, RO, SRB
Level of use of classical statistics without AI
National level BE, BG, CZ, DK, EE, FR, FI, IT, NL, NO, PL, PT, SK, SW, UK- WL
Sub-national
level




*Two countries (CZ & SK) use classical statistic in routine (i.e., advanced) but also developing further this technology (i.e., in progress)
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Sweden and Wales, use linked data in routine public
health surveillance to estimate the incidence and preva-
lence of diabetes (Additional file 6).
Health determinants
Participants were also asked to report the corresponding
determinants of the identified health conditions. 34
health determinants related to various health conditions
were reported by 15 member states (Table 3.2). These
determinants are related to the physical environment
(12), socioeconomic status and the environment (10),
health behavior and lifestyle (6) and biological and meta-
bolic parameters (3) (Additional file 7). These determi-
nants were used to measure the potential associations
between these risk factors and health conditions for pub-
lic health monitoring and research purposes. These de-
terminants can be stratified by age, sex, socioeconomic
status and by area of residence. For example in England
and Wales, in relation to the physical environment, the
proximity of fast food outlets from areas of residence is
used to measure its potential association with chronic
health conditions such as adiposity and obesity. This
variable can be stratified by the area of residence (Add-
itional file 7).
Health intervention indicators
Participants were asked to report at least three health
intervention indicators under three categories (i.e., pre-
vention, promotion, others) corresponding to the given
health conditions which are most important for public
health in their country. Using linked data, 23 health
intervention indicators related to the following six health
conditions were reported from 17 member states: mater-
nal and perinatal health (7), cancer (6), diabetes (4), car-
diovascular (2), neurodegenerative disease (2), suicide/
trauma/injury (1) and lower/upper respiratory infections
(1), (Additional file 8). The main objectives to estimate
these indicators were to guide the health policy process,
public health monitoring and for research. These inter-
vention indicators are estimated mainly at national and
sub-national levels and currently are in use. For example
in Sweden, one of the estimated intervention indicator
relates to preventive therapy, the number of diabetic pa-
tients counselled by a nurse to avoid complications
(Additional file 8).
v. Main obstacles to linking different data sources
The majority of European countries we surveyed iden-
tified the following main obstacles associated with the
implementation and the use of data linkage and ad-
vanced statistics: 1. The complex laws and data protec-
tion regulations, which block linkage between different
data sources with a deterministic approach (legal), 2.
Lack of human resources and capacities/skills within na-
tional institutes of public health and health information
statistics (technical), 3. Lack of governance of health in-
formation (data governance) and 4. Limited resources to
support the health information infrastructure
(organization and structural).
Discussion
The results of this study showed the variability in the
use of data linkage and AI at national institutes of public
health, health information and statistics across European
countries. The majority of countries use data linkage in
routine by applying either deterministic or a combin-
ation of two types of linkages (i.e., deterministic & prob-
abilistic) for public health surveillance and research
purposes. The use of a universal unique identifier, social
security number or unique pseudonymous identifier is
common to applying deterministic linkage technique
among European countries. The use of AI is less com-
mon to estimate health indictors at national public
health institutes. Across European countries, using data
linkage, 46 health outcome indicators related to seven
health conditions, 34 related to determinants and 23
health intervention indicators were reported. Some ini-
tiatives are ongoing as pilot projects to test these tech-
niques to improve health surveillance and to guide
health policy development. Four main obstacles to link-
ing different data sources have been identified by the
European experts.
A systematic review has shown that data linkage is
used in the field of perinatal health for both health sur-
veillance and research purposes in European countries
[8]. Several other studies have shown that linkage is used
to explore various dynamics of population health such
as social care, psychotic disorders, multi-morbidity, dia-
betes, obesity, mental health, cardiovascular, antibiotic
use and Alzheimer using data linkage with different
types of administrative data sources (both related to
health and non-health) [7, 18–30]. For the surveillance
of cancer, data linkage not only provides the opportunity
to improve the population-based screening [31] but it
also helps to detect different types of cancer recurrence
[32] and to evaluate the socio-economic status of pa-
tients with cancer (e.g., return to work) [33]. Linked data
also allows evaluating the health interventions at various
levels of the population [34]. The diversity and the vol-
ume of health information have been increasing rapidly
and push to discover new parameters to improve popu-
lation health with innovative approaches. In that context,
some initiatives have been launched at national level to
create health data hub/platform to be used for research
and to guide the policy development process [35, 36].
As for AI, there are some studies available which have
discussed the advantages of using this technology for
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early detection and diagnosis of certain medical condi-
tions, for treatment, as well as for outcome prediction
and prognosis evaluation with a high level of precision
[11, 37] but the use of AI at population level to estimate
and predict health indicators remains limited [38]. Fur-
thermore, this technique also permits exploring under-
lying unobserved trends and patterns in large datasets
without priori hypothesis.
Our results highlighted that a few member coun-
tries have achieved the most advanced levels of data
linkage by linking health information (i.e., clinical,
biobanks/laboratory tests, genetics) with non-health
population data sources and registers of education,
occupation, housing quality, air pollution, criminal
statistics and transport/road accidents, etc. These in-
novative linkages offer the exceptional opportunities
to enrich information, investigate non-health determi-
nants and to perform high quality epidemiological re-
search, health surveillance, to guide health policies to
improve population health. These innovative linkages
are especially relevant and of high value when consid-
ering health-in-all policies approaches. However, the
majority of European countries have not reached that
level of use in data linkage and AI and underlined
main obstacles associated with the implementation
and the use of data linkage and AI. These are related
to legal, technical and data governance issues as well
as organizational and structural aspects.
To address these issues and to increase the uptake of
innovative and high-performance technologies in public
health activities, we propose the following recommenda-
tions: A. Legal aspects: 1. More flexible data governance
frameworks to support data linkage of different data
sources should be encouraged [39], 2. Specific mandates
to ensure data availability/access/capture and safe stor-
age should be an integral part of a national/regional
health information system, 3. Differences in the imple-
mentation and interpretation of the EU-GDPR (General
Data Protection Regulations) and additional national
regulations should be mapped and if possible harmo-
nized across EU-MSs [40]; B. Technical aspects: 4. More
collaborations and partnerships should be encouraged to
build up capacities for using new health information re-
lated technologies, to share new methods, skills, experi-
ences and data for comparative research studies among
EU national institutes of public health, health informa-
tion and statistics; C. Data governance, 5. Initiatives to
strengthen national health information infrastructure
should be encouraged; D. Organizational and structural
aspects, 6. Ministries of health and research from Euro-
pean countries should provide their support (i.e., finan-
cial and political) for the development of integrated
national health data hubs/data platforms to strengthen
the national health information infrastructure.
There are a few limitations in this study. First, our
study may not have a complete coverage of data linkage
practices within countries. The current linkages reported
by national institutes of public health, health information
and statistics we surveyed may differ from those con-
ducted by other research institutes in that country which
we did not cover in the survey. This might influence the
results of this study. Second, we acknowledge that there
are other innovative methods exist such as use of data
clouds or blockchain. However, these methods are not
frequently used for routine public health surveillance
and research purposes. Third, we limited the response
burden of health indicators to three priority health con-
ditions. Therefore, our results do not constitute an ex-
haustive list of health indicators that are used in the
country to inform policy and practice. It may limit the
number of health indicators being estimated using linked
data and advanced statistics. Nevertheless, this survey
provides the latest overview of current practices in data
linkage and AI in European countries and highlights the
related obstacles in using these technologies for routine
public health activities.
Conclusions
To our knowledge, this is the first study, which provides
the information on current practices of data linkage and AI
use at national institutes of public health, health informa-
tion and statistics across European countries. Our results
highlight that the majority of countries have integrated data
linkage in their routine public health activities but few use
AI. The European countries who are advanced in using
both techniques i.e., data linkage and AI, could guide others
by an exchange of their experiences and examples of good
practices. A sustainable national health information system
and flexible data governance frameworks to link different
data sources are essential to support evidence-based prac-
tices for health policy development. Building analytical cap-
acity and raising awareness of the added value of data
linkage in national institutes of public health, health infor-
mation and statistics is necessary for increasing the use of
linked data in order to improve the quality of public health
surveillance and monitoring activities. The recommenda-
tions we have put forth could ultimately contribute to
strengthening national health information systems in Eur-
ope and would facilitate moving towards the establishment
of an integrated EU- Health Information System.
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